Updates

August 4, 2020August 4, 2020
Protein May Be Biomarker to Help Identify Difficult-to-diagnose MG, Study Says

High levels of kappa free light chain — a protein that makes up a portion of immunoglobulins (antibodies) — in the bloodstream may indicate ... Read more
July 31, 2020August 5, 2020
Argenx Plans FDA Submission of Efgartigimod by Year’s End

Argenx is planning to submit an application to the U.S. Food and Drug Administration (FDA) by the end of this year for its lead ... Read more
July 28, 2020August 4, 2020
Case Supports Soliris as Promising Treatment for Thymoma-associated MG

Soliris (eculizumab) may be a promising treatment option for patients with refractory myasthenia gravis (MG) associated with a tumor in the thymus ... Read more
July 24, 2020July 31, 2020
Long-term Soliris Therapy Leads to Sustained Muscle Strength Improvement, Studies Show

Treatment with Soliris (eculizumab) led to rapid and sustained improvements in muscle strength and the ability to perform daily activities in people ... Read more
July 21, 2020July 21, 2020
Stress and Depression Linked With Relapses in MG Patients

Stress and depression are associated with higher relapse rates in people with myasthenia gravis (MG), according to a recent study. Attention to evidence of ... Read more

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

September 28, 2017September 28, 2017

Women with Myasthenia Gravis Report Lower Quality of Life than Male MG Patients, Study Finds

News

Women with myasthenia gravis (MG) have a poorer quality of life than male patients. That’s the conclusion of a study named “Best Abstract Award” winner at the 2017 American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Annual Meeting in Phoenix. Specifically, ... Read more

Updates

Protein May Be Biomarker to Help Identify Difficult-to-diagnose MG, Study Says

Argenx Plans FDA Submission of Efgartigimod by Year’s End

Case Supports Soliris as Promising Treatment for Thymoma-associated MG

Long-term Soliris Therapy Leads to Sustained Muscle Strength Improvement, Studies Show

Stress and Depression Linked With Relapses in MG Patients

Subscribe to our mailing list

Protein May Be Biomarker to Help Identify Difficult-to-diagnose MG, Study Says

Argenx Plans FDA Submission of Efgartigimod by Year’s End

Case Supports Soliris as Promising Treatment for Thymoma-associated MG

Long-term Soliris Therapy Leads to Sustained Muscle Strength Improvement, Studies Show

Stress and Depression Linked With Relapses in MG Patients

Dutch Trial to Test NMD670 Oral Treatment Candidate

Rituximab Effective for People With Refractory MG, Study Finds

Mitochondria Defects in Immune Cells May Cause MG, Study Says

Alexion Charitable Foundation Giving $1.1M to Assist Rare Disease Community During Pandemic

Rituximab More Beneficial if Given to gMG Patients Early, Study Finds

Nipocalimab Does Well in Top-line Results of Phase 2 Vivacity-MG Trial

Early Success After Thymectomy Predicts Long-term Benefits for MG Patients, Study Finds

CAAR T-cell Therapy Shows Early Potential for MuSK-linked MG

Coalition Will Address Racial Disparities in Rare Disease Communities

MG Illuminate Event and MG United, by Argenx, Shine Light on Rare Disease

Efgartigimod Ably Treats AChR-positive Patients in Phase 3 Trial, Data Show

COVID-19 Delaying Rare Disease and Gene Therapy Trials, Pharma Execs Say

MGFA Promoting Ways to Recognize June, MG Awareness Month

Eurordis Urges Expansion of Newborn Screening Initiatives Across Europe

Unity and EU-wide Efforts Focus of Online Rare Disease Meeting

Myasthenia Gravis Has Made Planning for Motherhood Challenging

Thymectomy Seen to Aid Remission in Ocular MG Patients Younger Than 40

Rituximab Safe and Effective in LOMG, Study Suggests

Rare Diseases Clinical Research Network Opens Online Survey on COVID-19

Botox Injections Linked to Symptoms That Mimic Myasthenia Gravis

NORD Webinar Outlines COVID-19 Response on Financial, Policy Fronts

Industry leaders seek to advance innovative resources for rare and orphan disease communities amid COVID-19 outbreak

Surge in Telemedicine One ‘Good’ Outcome from COVID-19 Crisis, Doctors Say

Women with Myasthenia Gravis Report Lower Quality of Life than Male MG Patients, Study Finds

Pin It on Pinterest